- Home
- WDI vs CRMD Comparison
WDI vs CRMD Comparison
Compare WDI & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WDI | CRMD |
|---|---|---|
| Founded | 2021 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 715.3M | 590.7M |
| IPO Year | N/A | 2009 |
Fundamental Metrics
Financial Performance| Metric | WDI | CRMD |
|---|---|---|
| Price | $12.75 | $8.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $14.83 |
| AVG Volume (30 Days) | 222.5K | ★ 1.4M |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | ★ 11.80% | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | ★ 1.12 | 0.72 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.49 | ★ $11.47 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $12.75 | $6.13 |
| 52 Week High | $15.28 | $14.64 |
Technical Indicators
Market Signals| Indicator | WDI | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 30.53 | 56.18 |
| Support Level | N/A | $7.19 |
| Resistance Level | $13.86 | $8.93 |
| Average True Range (ATR) | 0.12 | 0.43 |
| MACD | -0.01 | 0.05 |
| Stochastic Oscillator | 3.75 | 60.53 |
Price Performance
Historical ComparisonAbout WDI Western Asset Diversified Income Fund of Beneficial Interest
Western Asset Diversified Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income. As a secondary investment objective, the Fund will seek capital appreciation. The fund seeks to achieve its investment objectives by investing, under normal market conditions, across fixed income sectors and securities in seeking to deliver a well-diversified portfolio.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.